INVO Fertility, Inc. (IVF) Form 8-K — Jun 2, 2026
INVO Fertility, Inc. (Nasdaq: IVF) reported fiscal year 2025 financial results, showing total revenue of $6.84 million, a 5% increase year-over-year. Consolidated clinic revenue rose 4% to $6.72 million, while net loss from continuing operations improved significantly to $5.3 million from $7.7 million in the prior year. The company highlighted recent balance sheet strengthening, citing $11.5 million in aggregate gross proceeds from financing transactions in late 2025 and early 2026.
Key figures
- Revenue
- 6841250
- Revenue Yoy
- 5%
- Shares Outstanding
- 1800000
- Total Revenue All Clinics
- 8021929
- Family Beginnings Revenue
- 1200000
- Recent Financing Proceeds
- 11500000
- Consolidated Clinic Revenue
- 6721057
Price after filing
Close on the filing date to close N calendar days later (from $1.52). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.